E-ISSN:2456-3110

Research Article

Hypothyroidism

Journal of Ayurveda and Integrated Medical Sciences

2023 Volume 8 Number 2 February
Publisherwww.maharshicharaka.in

A clinical study to evaluate the efficacy of Kanchnara Twak Kwatha with Shunthi Churna and Nimba Taila Nasya in Hypothyroidism

Yadav P.1*, Kumar A.2, Singhal T.3
DOI: http://dx.doi.org/10.21760/jaims.8.2.4

1* Pratima Yadav, Post Graduate Scholar, Department of Panchakarma, Govt. Postgraduate Ayurveda College & Hospital, Varanasi, Uttar Pradesh, India.

2 Ajay Kumar, Assistant Professor, Department of Kayachikitsa & Panchakarma, Govt. Postgraduate Ayurveda College & Hospital, Varanasi, Uttar Pradesh, India.

3 Tina Singhal, Assistant Professor, Department of Rachana Sharir, Govt. Postgraduate Ayurveda College & Hospital, Varanasi, Uttar Pradesh, India.

Context: Hypothyroidism is a clinical syndrome resulting from deficiency of thyroid hormones due to their insufficient synthesis which is turn result in generalized slowing down of metabolic process characterized by broad clinical spectrum ranging from an asymptomatic or subclinical condition to fully manifested clinical condition. It is more common in females than males with middle age women more effected. Materials and Methods: Sixty eligible hypothyroid patients with serum thyroid-stimulating hormone >4.5 μIU/ml and serum T3 and T4 lower than their respective normal range were selected and treated with Kanchnar Twak Kwath with Shunthi Churna and Nimb Taila Nasya for 45 days. Patients were advised to discontinue any medicine they might be taking for the management of hypothyroidism to assess the unbiased effect of therapies. Results: Significant improvement was observed on subjective parameters, and objective parameters. Of the 60 enrolled patients, In group B maximum improvement 62.07%, moderate improvement 20.69%, mild improvement 13.79%, no improvement 3.45%. But in group A maximum improvement 7.14%, moderate improvement 28.57%, mild improvement 42.86%, no improvement 21.43%. after this trial maximum patient had withdrawn their hormone replacement therapy. Conclusion: Kanchnar Twak Kwath with Shunthi Churna and Nimba Taila Nasya are effective in the management of hypothyroidism.

Keywords: Hypothyroidism, Kanchnar Twak Kwath, Nimb Tail Nasya, Shunthi Churna

Corresponding Author How to Cite this Article To Browse
Pratima Yadav, Post Graduate Scholar, Department of Panchakarma, Govt. Postgraduate Ayurveda College & Hospital, Varanasi, Uttar Pradesh, India.
Email:
Pratima Yadav, Ajay Kumar, Tina Singhal, A clinical study to evaluate the efficacy of Kanchnara Twak Kwatha with Shunthi Churna and Nimba Taila Nasya in Hypothyroidism. J Ayu Int Med Sci. 2023;8(2):20-29.
Available From
https://jaims.in/jaims/article/view/2277

Manuscript Received Review Round 1 Review Round 2 Review Round 3 Accepted
2023-12-20 2023-12-22 2023-12-29 2023-01-06 2023-01-13
Conflict of Interest Funding Ethical Approval Plagiarism X-checker Note
Nil Nil Yes 19%

© 2023by Pratima Yadav, Ajay Kumar, Tina Singhaland Published by Maharshi Charaka Ayurveda Organization. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License https://creativecommons.org/licenses/by/4.0/ unported [CC BY 4.0].

Introduction

Hypothyroidism results in slowing of metabolic process and energy expenditure. It results in a many of clinical signs and symptoms. The Kapha symptoms like lethargy, sleepiness, weight gain, decreased appetite, cold intolerance, fullness in the throat, hoarseness of voice, etc. are produced. The Vata symptoms like fatigue, loss of energy, dry skin, hair loss, muscle pain, joint pain, blurred vision, weakness in the extremities, mental disfigurement, forgetfulness, impaired memory, constipation, menstrual disturbances, impaired fertility, decreased perspiration.

These all symptoms are produced due to increment of Kapha-Vata mainly. Vitiation of Doshas also depends on vitiations of Agni that is why, Acharya Vagbhatta has said that [1] Pathophysiology of all diseases lies in the concept of Agni, as Agni is said to be the Prana(life) of the living body. Also, body is made up of Dosha, Dhatu, and Mala Nourishment of each of these solely depends on balanced Agni of each Dhatu.[2]

As said by Acharya Charak:[3]Srotas vitiation also depends on Agni. So, it is clear that in hypothyroidism there is abnormality of Agni with abnormality of Kapha and Vata Doshas as well as Rasavaha, Raktavaha, Medovaha, Sukravaha and Manovaha Srotas.

The main treatment of hypothyroidism in modern medicine is hormone replacement therapy.[4] But hormone (levothyroxine) has to be taken life long and has certain side effects on long term use.

It all starts with improper diet (heavy, cold, sweet and saturated fat containing food items) and sedentary lifestyle (lack of physical activity, sleeping after meals, sleeping during day time) which is now-a-day very common. It leads to aggravation of Kapha Doshas. Due to increased amount of Kapha impairs the Jatharagni so, formation of Aamdosha occur. As Dhatvagni depends on Jatharagni Bala, so impairment of Dhatvagni occur. According to Ayurveda, due to vitiation of Dhatvagni can be compared with effect of hypothyroidism i.e., alteration in metabolic activity. So, this Dhatvagni vitiation causes improper formation of Sapta Dhatu starting from Rasa to Shukra. It leads to improper nourishment to the body leading to symptoms of hypothyroidism along with swelling in neck described as ‘Galganda’ in Ayurvedic texts.

Hypothyroidism is a disease with Kapha Vata predominance and Pittakshaya. In hypothyroidism Jatharagni Mandhya leads to Dhatvagni Mandhya. So therefore, we have selected a drug which is Kapha Vata Shamak property. So, we have used Kanchanar Twak Kwath with Shunthi Churna and Nimb Taila Nasya for treatment of hypothyroidism. Further hypothyroidism is a disease which may also be due to auto immunity.

Kanchnar which has Kashaya in Rasa, Laghu, Ruksha Guna, Kapha-Pitta Shamak, and Gandamalanaashan property.[5] Shunthi which has Katu Rasa, Laghu Snigdh Guna, and Kapha Vata Shaamak.[6] Nimba has Tikta Kashaya Rasa, Kapha Pitta Shaamak and Raktashodhan property.[7]

Aims and Objective

1. To assess the efficacy of the trial drugs in the cases of hypothyroidism.

2. To normalize the level of T.S.H. and other symptoms in the cases.

3. To gradually decrease the hormone (levothyroxine) with the trial drugs.

4. To find out the easily available, economical safe and effective remedy for the treatment of Hypothyroidism.

Materials and Methods

Plan of the study: The study was carried out after getting clearance from IEC and CTRI registration.

Institutional ethics clearance number: RAC-IEC-19-M.D.-04, Dated 25.01.2021

CTRI registration number: CTRI/2021/04/033150 [Registered on 27.04.2021]

Trial Registered prospectively

Type of trial: Interventional

Randomized Sampling: Computer generated randomization Method

Nature of Study design: Randomized, Parallel Group Trial

Type of Study: Interventional Open Randomized clinical study.

Period of Study: Total duration of clinical trial was 45 days with fortnightly follow-up for symptoms and monthly follow-up for thyroid function test.


Sample Size: Total 60 patients of hypothyroidism were registered for this study. Among these 3 patients were drop out.

Grouping: Minimum 60 patients of hypothyroidism from OPD and IPD of Govt. P.G. Ayurveda College and Hospital, Varanasi were selected and treated with trial drugs. Patients who are using the modern drug Levothyroxine was given the trial Ayurveda drug after wash out period of at least 15 days. There were two groups.

Group A: 30 Patients were registered in Group-A, out of which 2 patients drop out. Remaining 28 patients were treated with Kanchnar Twak Kwath 50 ml with 1gm Shunthi Churna two times in a day before meal.

Group B: 30 patients were registered in Group-B, out of which 1 patient drop out, remaining 29 patients were treated with Kanchnar Twak Kwath 50 ml with 1 gm Shunthi Churna two times in a day before meal and Nimb Taila Nasya 2 drops in each nostril.

Selection of patients

A total of 60 patients suffering from hypothyroidism were selected from outdoor patient department and indoor patient department of Panchakarma, Govt. Ayurveda college and Hospital, Varanasi, irrespective of their sex, religion, caste, occupation etc.

Ethical clearance was obtained from the Institutional ethics clearance No. RAC-IEC-19-M.D.-04, dated 25.01.2021. This study is registered in Clinical Trial Registry of India with registration no. CTRI/2021/04/033150. Informed written consent in language suitable to the patients was obtained from all enrolled participants.

Inclusion criteria

  • Age between 20-60 years.
  • Patients who are freshly diagnosed case of hypothyroidism with increased T.S.H. levels
  • S.H. level >4.5 µIU/ml.
  • Total serum T4 level less than normal value (total serum T4=4.5-12.5 µg/dl)
  • Total serum T3 level less than normal value (total serum T3=80-220 ng/dl)
  • Patients having clinical features of Hypothyroidism;

a. Puffiness of the face and eyelids

b. Peripheral edema

c. Dry/coarse skin

d. Breathlessness

e. Constipation

f. Weakness

g. Lethargy

h. Fatigue

i. Muscle ache

j. Duration of menstrual blood(female)

k. Interval between two cycles(female)

l. Hair fall

  • Patients who are ready to switch over to Ayurvedic medicine and have signed the consent form.

Exclusion criteria

  • Patients below 20 years and above 60 years of age.
  • If patients undergone any type of thyroid surgery.
  • Patients whose symptoms are aggravated after leaving the modern drug levothyroxine (for washout period)
  • Patients suffering from systemic diseases like cardiac problems, diabetes HTN and carcinoma etc.
  • Congenital hypothyroidism and secondary hypothyroidism
  • Pregnant women, hyperthyroidism, neoplasia, toxic goitre is excluded.

Laboratory Investigation: Following laboratory investigations were performed for proper diagnosis and to rule out major pathological conditions.

  • Biochemical parameters like Thyroid profile (Serum T3, Serum T4 and TSH) lipid profile, liver function test, RBS, Serum creatinine, Blood urea.
  • Haematological parameters like Hb%, TLC, DLC, ESR.

Drugs and dosage: Kanchnar Twak Kwath 50 ml with 1 gm Shunthi churna two times in a day before meal.[8]


Nimb Taila Nasya[9] 2 drops in each nostril.

The trial drugs were procured from Pharmacy, Sampoornanad Sanskrit University.

Preparation method of trial drugs

Preparation of Kanchnar Twak Kwath with Shunthi Churna: Patients were advised to boil coarse powder of Kanchnar Twak Kwath in eight parts of water and reduce it up to 50 ml and mixed with 1 gm Shunthi Churna before meal.

Nimb Tail Nasya - 2 drops in each nostril.

The trial drugs were administered for 45 days.

Follow-up study: After completion of the therapy, patients were followed for 15 days.

Subjective and Objective criteria

Percentage of improvement in each parameter was calculated. Paired ‘t’ test was applied to the data to analyse the effect of therapy on subjective and objective parameters. The results were interpreted at P < 0.05, P < 0.01 and P < 0.001 significance levels.

Observations and Results

Out of the 60 registered patients, maximum patients belonged to age group of 31-40 years and 41-50 years (29.82%) and majority of the patients were female 89.47%.

The study showed that middle economical group was affected mostly 59.65%. Maximum no. of patients 52.63% were House-wives followed by other 24.56%, Private 22.81%, about 70.18% of the patients were married, Mandagni was observed in 59.65% of the patients, 59.65% of the patients were Krura Kostha, Maximum no. of patient 70.18% were suffering from constipation habit, maximum no. of patient 57.89% were of Vata-Kapha Prakrati.

Effect of therapy on presenting complaints of hypothyroidism

The results were significant in all the signs and symptoms of hypothyroidism. Highly significant improvement (P < 0.001) was observed in puffiness of the face and eyelid, oedema, dry/coarse skin, constipation, weakness, fatigue and muscle ache, duration of menstrual blood, interval between two cycles and hair fall.

Table 1: Showing the effect of symptoms in Group A.

Paired Samples Statistics Paired Differences
Group (A) N Mean Std. Dev S.E. % Change t df p-value Result
Puffiness of the face and eyelid BT 28 1.93 0.72 0.14 37.04 6.30 27 <0.001 HS
AT 28 1.21 0.63 0.12
Edema BT 28 1.86 0.76 0.14 25.00 4.26 27 <0.001 HS
AT 28 1.39 0.50 0.09
Dry coarse skin BT 28 2.32 0.61 0.12 20.00 4.84 27 <0.001 HS
AT 28 1.86 0.59 0.11
Constipation BT 28 2.36 0.62 0.12 22.73 4.92 27 <0.001 HS
AT 28 1.82 0.72 0.14
Weakness BT 28 2.36 0.62 0.12 22.73 5.58 27 <0.001 HS
AT 28 1.82 0.61 0.12
Lethargy BT 28 2.36 0.62 0.12 24.24 4.77 27 <0.001 HS
AT 28 1.79 0.63 0.12
Fatigue BT 28 2.29 0.66 0.12 29.69 4.77 27 <0.001 HS
AT 28 1.61 0.57 0.11

jaims_2277_01.JPG

Table 2: Showing the effect of symptoms in Group A.

Paired Samples Statistics Paired Differences
Group (A) N Mean Std. Dev S.E. % Change t df p-value Result
Muscle ache BT 28 2.36 0.62 0.12 24.24 5.28 27 <0.001 HS
AT 28 1.79 0.57 0.11
Duration of menstrual blood BT 28 1.78 0.67 0.14 51.22 5.97 27 <0.001 HS
AT 28 0.87 0.63 0.13
Interval Bw 2 cycle BT 28 2.39 0.66 0.14 43.64 6.52 27 <0.001 HS
AT 28 1.35 0.65 0.13
Hair fall BT 28 1.75 0.52 0.10 32.65 5.28 27 <0.001 HS
AT 28 1.18 0.55 0.10

jaims_2277_02.JPG

Table 3: Showing the effect of symptoms in Group B.

Paired Samples Statistics Paired Differences
Group (B) N Mean Std. Dev S.E. % Change t df p-value Result
Puffiness of the face and eyelid BT 29 2.07 0.70 0.13 80.00 13.31 28 <0.001 HS
AT 29 0.41 0.50 0.09
Edema BT 29 2.28 0.59 0.11 80.30 16.36 28 <0.001 HS
AT 29 0.45 0.51 0.09
Dry coarse skin BT 29 2.14 0.69 0.13 83.87 19.65 28 <0.001 HS
AT 29 0.34 0.48 0.09
Constipation BT 29 2.34 0.61 0.11 77.94 16.36 28 <0.001 HS
AT 29 0.52 0.51 0.09
Weakness BT 29 1.97 0.68 0.13 80.70 10.95 28 <0.001 HS
AT 29 0.38 0.49 0.09
Lethargy BT 29 2.41 0.57 0.11 80.00 17.52 28 <0.001 HS
AT 29 0.48 0.51 0.09
Fatigue BT 29 2.38 0.56 0.10 84.06 15.23 28 <0.001 HS
AT 29 0.38 0.49 0.09

jaims_2277_03.JPG



Table 4: Showing the effect of symptoms in Group B.

Paired Samples Statistics Paired Differences
Group (B) N Mean Std. Dev S.E. % Change t df p-value Result
Muscle ache BT 29 2.21 0.62 0.12 82.81 16.36 28 <0.001 HS
AT 29 0.38 0.49 0.09
Duration of menstrual blood BT 29 1.93 0.73 0.14 76.92 11.98 28 <0.001 HS
AT 29 0.44 0.51 0.10
Interval Bw 2 cycle BT 29 2.22 0.58 0.11 81.67 15.15 28 <0.001 HS
AT 29 0.41 0.50 0.10
Hair fall BT 29 2.34 0.61 0.11 76.47 14.30 28 <0.001 HS
AT 29 0.55 0.63 0.12

jaims_2277_04.JPG

Table 5: Showing the effect of Weight and BMI in Group A.

Paired Samples Statistics Paired Differences
Group (A) N Mean Std. Dev. S.E. % Change t df p-value Result
Weight BT 28 60.11 7.23 1.37 0.71 2.06 27 0.050 NS
AT 28 59.68 7.27 1.37
BMI BT 28 25.19 3.16 0.60 0.65 1.92 27 0.066 NS
AT 28 25.03 3.22 0.61

Table 6: Showing the effect of Weight and BMI in Group B.

Paired Samples Statistics Paired Differences
Group (B) N Mean Std.Dev. S.E. % Change t df p-value Result
Weight BT 29 61.79 10.11 1.88 4.46 10.21 28 0.000 HS
AT 29 59.03 9.98 1.85
BMI BT 29 25.97 3.74 0.69 4.46 10.20 28 0.000 HS
AT 29 24.81 3.67 0.68

The above table clearly depicts that in all the groups, mean Weight values was in abnormal range before and after the treatment.


In group A, before treatment the mean score 60.11 and after 45 days of intervention mean score 59.68 which is statistically not significant p value-.050 (p>0.05). In group B, before treatment the mean score 61.79 and after 45 days of intervention mean score 59.03 which is statistically highly significant P value- 0.000 (p<0.05). Agnimandya causes weight gain in hypothyroidism. Because of the Agnimandya state, the degree of Meda Dhatu increased due to Mandhyata of Meda Dhatwagni. Weight gain is primarily caused by lethargy-like symptoms that cause patients to avoid physical activity. Shunthi causes Aamapachana and may aid to reduce fluid retention due to its qualities such as Deepana, Pachana, and Vatakaphahara property. The effect of Shunthi has been determined to be significant in terms of body weight improvement in studies.[10]

The above table clearly depicts that in all the groups, mean BMI values was in abnormal range before and after the treatment. In group A, before treatment the mean score 25.19 and after 45 days of intervention mean score 25.03 which is statistically not significant P value-0.066 (p>0.05). In group B, before treatment the mean score 25.97 and after 45 days of intervention mean score 24.81 which is statistically highly significant (p<0.05).

Table 7: Showing the effect of Thyroid profile in Group A.

Paired Samples Statistics Paired Differences
Group (A) N Mean Std.Dev. S.E. % Change t df p-value Result
S T3 BT 28 1.20 0.75 0.14 2.05 1.66 27 0.108 NS
AT 28 1.18 0.68 0.13
S T4 BT 28 5.74 1.76 0.33 0.36 0.41 27 0.687 NS
AT 28 5.72 1.67 0.32
S TSH BT 28 13.56 18.28 3.45 5.97 2.02 27 0.053 NS
AT 28 12.75 17.38 3.28

Table 8: Showing the effect of Thyroid profile in Group B.

Paired Samples Statistics Paired Differences
Group (B) N Mean Std. Dev. S.E. % Change t df p-value Result
S T3 BT 29 1.06 0.36 0.07 60.10 -10.07 28 0.001 HS
AT 29 1.70 0.13 0.02
S T4 BT 29 6.27 1.62 0.30 17.70 -12.61 28 0.001 HS
AT 29 7.38 1.52 0.28
S TSH BT 29 6.94 2.95 0.55 36.70 5.80 28 0.000 HS
AT 29 4.39 0.75 0.14

Before treatment mean score 1.20 in Group A and 1.06 in Group B.

After treatment mean score 1.18 in Group A and 1.70 in Group B. There was no significant improvement in T3 level in Group-A (P value-0.108) and highly significant effect on Group-B (P value-0.001).

Before treatment mean score 5.74 in Group A and 6.27 in Group B.

After treatment mean score 5.72 in Group A and 7.38 in Group B. There was no significant improvement in T4 level in Group-A (P value-0.687) and highly significant effect on Group-B (P value-0.001).

Before treatment mean score 13.56 in Group A and 6.94 in Group B. After treatment mean score 12.75 in Group A and 4.39 in Group B. There was no significant improvement in TSH level in Group-A (P value-0.053) and highly significant effect on Group-B (P value-0.000). Agnimandya and Uttrottar Dhatu Mandyata are the main causes of hypothyroidism.

The drugs Kanchnar and Shunthi both function as Deepan so, Agni Saamyata occurs. According to Acharya Charak Galagand, Gandamala mainly due to Mamsa Dhatu Dushti, and Kanchnar's Gandamalanashan ability to control thyroid hormones.

Effect of therapy on haematological parameters and lipid profile

There was statistically insignificant change (P > 0.05) in all the haematological parameters and highly significant change (P<0.05) in lipid profile.

Changes in lipid profile like Sr. cholesterol, Sr. triglycerides, HDL, LDL, VLDL were insignificant in group A and highly significant in group B.

Thyroid hormones aid in the reduction of lipid levels by potentiating the effect of catecholamines and other lipolytic hormones. Thyroid hormones enhance lipolysis by potentiating the action of catecholamines and other lipolytic hormones and help in reducing the lipid levels.

Overall effect of therapy

Maximum improvement was found in 62.07% of the patients, 20.69% of the patients showed moderate improvement, 13.79% of the patients showed mild improvement and 3.45% of the patients showed no improvement.



Table 9: Effect of Overall therapy in different groups

SN Results Range Group A Group B
No of Pt. % No of Pt. %
1. Maximum Improvement 75% & Above 2 7.14 18 62.07
2. Moderate Improvement 50% to 75% 8 28.57 6 20.69
3. Mild Improvement 25% to 50% 12 42.86 4 13.79
4. No Improvement 25% & Less 6 21.43 1 3.45
  Total 28 100.00 29 100.00

Discussion

Thyroid diseases affect 42 million people in India, the most frequent of which is hypothyroidism. Hypothyroidism is a thyroid hormone deficiency that can impact the function of nearly every system in the body. Thyroxine is an iodine-containing hormone released by the thyroid gland that regulates growth and boosts cell metabolism.

Thyroid hormone has the overall impact of activating nuclear transcription of a wide number of genes. As a result, a large number of protein enzymes, structural proteins, transport proteins, and other compounds are created in practically every cell of the body. As a result, there is a widespread increase in functional activity across the body. Iodine can be considered as Tejomahabhutamsha and its main content of thyroid hormones.[11] So, it can be said that that thyroid hormones have Agni Amsha. Almost all of the body's chemical reactions would become sluggish if thyroid hormones were not produced by the thyroid gland. As a result, they can be considered a part of Kayagni, which is responsible for all metabolic activities.

Dahana, Pachana, and Satmikarana are three functions of the Agni that are linked to metabolic activity in the body. Thyroid hormones regulate the body's whole metabolic process. The concept of agni is very much unique in Ayurveda. Hypothyroidism in Ayurveda can be considered under a disease arising from malfunction of Agni as Agnidushti. According to Acharya Charak Jatharagni is the reason of longevity, colour strength, health, enthusiasm, intelligence, complexion, Ojas (immunity), Tejas (lusture), other varieties of Agni and Prana. Extinction of this Jatharagni leads to death, its power maintenance helps a person to live a long life and its impairment gives rise to disease.


Clinical presentation of Hypothyroidism also exhibits same symptoms like tiredness, letharginess, heaviness in body, sleepiness, loss of appetite. As in cases of Hypothyroidism there is involvement of Agnidushti which is compare with basal metabolic rate.

Keeping all these above point means the principle of vitiation of Agni in mind therefore, here an attempt is made to understand Hypothyroidism through Ayurvedic perspective and principles under the title "A Clinical study to evaluate the efficacy of Kanchnar Twak Kwath with Shunthi Churna and Nimb Tail Nasya in Hypothyroidism".

So, all three Doshas are involved, although hypothyroidism is largely a Kapha imbalance according to Ayurveda. Jatharagni Mandhya causes Dhatvagni Mandhya in hypothyroidism, so, we have chosen a medication with Kapha Vata Shamak properties.

Mode of action of trial drug (Kanchnar Kwath with Shunthi Churna)

Ruksha and Laghu Guna of Kanchnar Twak removes the Margavaran. According to the findings of this study, the majority of patients have Mandagni, hence the qualities of Deepan and Grahi work on the digestive system by increasing Agni.[12]

Shunthi has the same Deepan property as Kanchnar, therefore it helps to encourage the rise of Agni and Anulomaka, which helps to eradicate constipation because the majority of the patients in this study complained of incomplete evacuation. The properties like Ushna Veerya, Katu Rasa, Tikta Rasa, Laghu Guna favour to cleanse the Srotavrodha.[13] Shunthi with its Vata Kaphahara quality pacify the symptoms arising out of Vata Dosha and Kapha Dosha.

Mode of action Nimb Tail Nasya

Nimb Tail having Laghuguna, Snigdhguna, and Vatahara Kaphahara properties.[14] With the help of Laghu Guna, Bhedaniya Prabhava occur of this drug and Tikta Rasa helps in digestion. With its Katu Vipaka increase the Agni and improve the digestion. According to Acharya Sharangdhar Nimb Tail having Sukshmaguna so it reaches easily in microchannels of the body.[15] The administered oil is quickly absorbed through the nasal route. Tail helps to balance Vata while not aggravating Kapha and Ushna, Tikshna, and Vyavayi Gunas are


present in tail. As a result, it has a high capacity for penetrating narrow channels, allowing it to open congested pathways such as the sinus ostia and assist the drainage of collected effluent. Another therapeutic aspect of Tail is that when it is treated with other medications, it absorbs the properties of those drugs as well. When viewed from this perspective, Tail is the best Sneha Dravya since it not only merges the substance introduced to it, but it also gives up its own properties.

Conclusion

The present thesis entitled "A Clinical Study to Evaluate the Efficacy of Kanchnar Twak Kwath with Shunthi Churna and Nimb Tail Nasya in Hypothyroidism. To approached hypothyroidism with Dosha Pratyaneek Chikitsa, will help to manage condition better. It means this remedy is safe and effective which not only relieves symptoms but also increase sense of well being leading to more acceptability and better compliance. There is no side effect of hormonal replacement therapy like arrythmia etc. there is symptomatic satisfactory relief in most of cases. The remedy which normalizes the level of thyroid hormone and give symptomatic relief.

Reference

1. Vagabhata, Ashtanga Hridayam, Vidyotini with the Hindi Commentary of Kaviraja Atrideva Gupta, edited by Vaidya Yadunandana Upadhyaya: Chaukhamba Orientalia, Varanasi, 2016: Sutrasthana 12/1, p.358

2. Sushruta Samhita of Maharshi Sushruta, Edited with Ayurveda-Tattva-Sandipika, by Kaviraja Ambikadutta Shastri, Chaukhamba Sanskrit Sansthan, Varanasi 2007; Sutra Sthana 15/3.

3. Agnivesha, Charaka, Dridhbala Charaka Samhita, edited by Pt. Kashinatha Shastri and Dr.Gorakhnath Chaturvedi, Chaukhamba Bharti Academy,Varanasi 2013, Chikitsa Sthana. 15/3-4, p.452.

4. Strachan M.W.J, Newell- Price.J. Endocrine disease In: Colledge N.R., Walker B.R., Ralston S.H., Penman I.D.(Eds). Davidson’s principles and practice of medicine. 22nd ed. Edinburgh: Churchill Livingstone/Elsevier Ltd; 2014. pg.743.

5. Dravyaguna Vigyana, By Prof. P. V. Sharma, Vol-2, Chaukhambha Bharati Academy, Varanasi, Edition 2012.pg.234.

6. Dravyaguna Vigyana, By Prof. P. V. Sharma, Vol-2, Chaukhambha Bharati Academy, Varanasi, Edition 2012.pg.331.

7. Dravyaguna Vigyana, By Prof. P. V. Sharma, Vol-2, Chaukhambha Bharati Academy, Varanasi, Edition 2012.pg.149.

8. Bhavamishra, Bhavaprakasha Vidyotini Hindi Commentary edited by Bhishgratna Pandit Sri Brahma Shankar Mishra, Choukambha Sanskrit Bhawan Varanasi, reprint 2009, pg.449.

9. Chakrapanidatta, Chakradatta, with the Vidyotini Hindi commentary Indradeva Tripathi, edited by Acharya Ramnath Dwivedi, Choukambha Sanskrit Sansthan Varanasi, 3rd edition 1997, pg.246.

10. Dravyaguna Vigyana, Vol- 2nd by Dr. J.L.N. Sastry; Chaukhamba Orientalia Varanasi, Reprint Edition 2010; page no. 524.

11. M. Shrinivasulu. Concept of Aama in Ayurveda (with a chapter on Amavata and its management). Chowkhamba Sanskrit Series Office, Varanasi, chap 2 p. 28

12. The Ayurvedic Pharmacopoeia of India, Part-1, Volume-I, p.73.

13. The Ayurvedic Pharmacopoeia of India, Part-1, Volume- I p.138.

14. The Ayurvedic Pharmacopoeia of India, Part-1, Volume- V p.143.

15. Sharangadhara Samhita of Acharya Sarangdhar, By Dr. Smt. Shailaja Srivastava, Chaukhambha Orientalia, Varanasi, Edition 2017. Poorva khanda 4/19, p.33.